Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FUJIFILM Diosynth Biotechnologies Denmark ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.5% 4.5% 2.3% 2.2% 0.6% 0.8% 6.3% 6.0%   Credit score (0-100)   99 48 65 64 97 91 38 39   Credit rating   AAA BBB BBB BBB AA AA BBB BBB   Credit limit (mDKK)   415.5 0.0 0.1 0.1 490.7 524.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales   1,417 2,039 2,727 3,069 3,451 4,303 4,303 4,303   Gross profit   214 65.1 494 561 1,005 1,261 0.0 0.0   EBITDA   621 65.1 494 561 1,148 1,279 0.0 0.0   EBIT   318 65.1 494 561 659 868 0.0 0.0   Pre-tax profit (PTP)   322.0 -176.3 103.5 213.5 601.6 532.8 0.0 0.0   Net earnings   253.5 -176.3 103.5 213.5 470.3 400.2 0.0 0.0   Pre-tax profit without non-rec. items   322 65.1 494 561 602 533 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Tangible assets total   3,760 0.0 0.0 0.0 9,924 15,348 0.0 0.0   Shareholders equity total   3,938 3,762 3,865 4,079 4,549 4,949 4,949 4,949   Interest-bearing liabilities   98.9 0.0 0.0 0.0 6,247 12,679 0.0 0.0   Balance sheet total (assets)   4,541 5,495 5,848 8,456 13,684 20,501 4,949 4,949   Net Debt   -80.0 0.0 0.0 0.0 6,107 11,777 -4,860 -4,860     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales   1,417 2,039 2,727 3,069 3,451 4,303 4,303 4,303   Net sales growth   -0.0% 43.9% 33.7% 12.5% 12.4% 24.7% 0.0% 0.0%   Gross profit   214 65.1 494 561 1,005 1,261 0.0 0.0   Gross profit growth   -11.2% -69.6% 659.3% 13.5% 79.0% 25.5% -100.0% 0.0%   Employees   747 746 813 966 1,140 1,468 0 0   Employee growth %   5.4% -0.1% 9.0% 18.8% 18.0% 28.8% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,541 5,495 5,848 8,456 13,684 20,501 4,949 4,949   Balance sheet change%   2.8% 21.0% 6.4% 44.6% 61.8% 49.8% -75.9% 0.0%   Added value   621.2 65.1 494.4 561.3 659.4 1,279.4 0.0 0.0   Added value %   43.8% 3.2% 18.1% 18.3% 19.1% 29.7% 0.0% 0.0%   Investments   -474 -3,771 0 0 9,784 5,025 -15,621 0   Net sales trend   -1.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A EBITDA %   43.8% 3.2% 18.1% 18.3% 33.3% 29.7% 0.0% 0.0%   EBIT %   22.4% 3.2% 18.1% 18.3% 19.1% 20.2% 0.0% 0.0%   EBIT to gross profit (%)   148.3% 100.0% 100.0% 100.0% 65.6% 68.8% 0.0% 0.0%   Net Earnings %   17.9% -8.6% 3.8% 7.0% 13.6% 9.3% 0.0% 0.0%   Profit before depreciation and extraordinary items %   39.3% -8.6% 3.8% 7.0% 27.8% 18.9% 0.0% 0.0%   Pre tax profit less extraordinaries %   22.7% 3.2% 18.1% 18.3% 17.4% 12.4% 0.0% 0.0%   ROA %   7.3% 1.3% 8.7% 7.8% 7.1% 5.5% 0.0% 0.0%   ROI %   7.7% 1.3% 8.7% 7.8% 8.1% 6.5% 0.0% 0.0%   ROE %   6.7% -4.6% 2.7% 5.4% 10.9% 8.4% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Equity ratio %   86.7% 100.0% 100.0% 100.0% 34.4% 24.7% 100.0% 100.0%   Relative indebtedness %   25.8% 0.0% 0.0% 0.0% 253.3% 351.9% 0.0% 0.0%   Relative net indebtedness %   13.2% 0.0% 0.0% 0.0% 249.2% 330.9% -112.9% -112.9%   Net int. bear. debt to EBITDA, %   -12.9% 0.0% 0.0% 0.0% 531.9% 920.5% 0.0% 0.0%   Gearing %   2.5% 0.0% 0.0% 0.0% 137.3% 256.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.8% 0.0% 0.0% 0.0% 6.0% 4.3% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Quick Ratio   2.1 0.0 0.0 0.0 0.3 1.4 0.0 0.0   Current Ratio   2.1 0.0 0.0 0.0 0.4 1.6 0.0 0.0   Cash and cash equivalent   178.9 0.0 0.0 0.0 140.3 901.2 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 33.4 78.6 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   54.3% 0.0% 0.0% 0.0% 98.8% 111.4% 112.9% 112.9%   Net working capital   403.4 0.0 0.0 0.0 -5,331.0 1,817.3 0.0 0.0   Net working capital %   28.5% 0.0% 0.0% 0.0% -154.5% 42.2% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales / employee   2 3 3 3 3 3 0 0   Added value / employee   1 0 1 1 1 1 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1 0 1 1 1 1 0 0   EBIT / employee   0 0 1 1 1 1 0 0   Net earnings / employee   0 -0 0 0 0 0 0 0